AAM
Azzad Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $81.3K | Sell |
16,068
-743
| -4% | -$3.76K | 0.01% | 307 |
|
|
2025
Q1 | $88.9K | Buy |
16,811
+2,982
| +22% | +$15.8K | 0.01% | 298 |
|
|
2024
Q4 | $93.5K | Sell |
13,829
-1,168
| -8% | -$7.9K | 0.02% | 169 |
|
|
2024
Q3 | $98.8K | Sell |
14,997
-828
| -5% | -$5.46K | 0.01% | 301 |
|
|
2024
Q2 | $119K | Sell |
15,825
-367
| -2% | -$2.75K | 0.01% | 292 |
|
|
2024
Q1 | $161K | Buy |
+16,192
| New | +$161K | 0.02% | 295 |
|